Chase Theraputics
Manufacturing · District of Columbia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1825 K St NW Ste 510, Washington, Distri...Phone Number
(202) 568-8831Website
www.chasetherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Chase Theraputics
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease. Chase Therapeutics mission is to improve the quality of life for patients with brain disease and their caregivers. Parkinsons disease and related neurodegenerative disorders currently lack a disease-modifying treatment that would delay onset and slow progression. Other neuropsychiatric conditions including depression also need improved treatments that offer faster onset, greater efficacy and better tolerability. Chases goal is to validate the company's unique approach to discover and develop improved treatments for central nervous system disease; the company stand dedicated to optimizing this process with respect to time, cost and quality for the benefit of the company's patients and investors.Explore more
Chase Theraputics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chase Theraputics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Chase Theraputics
Funding: Get notified immidiatlly once Chase Theraputics has new funding data
Click to see if Chase Theraputics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Chase Theraputics is spiking on competitors!
Earning: See what the market has to say on Chase Theraputics recently announced quarterly report
Product Launch: Get notified when Chase Theraputics launches new products
Chase Theraputics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Chase Theraputics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Chase Theraputics
Find more new buyers
Compare Similar Companies to Chase Theraputics
Compare insights from companies similar to Chase Theraputics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2011
Mark KlevenSenior Vice President, Scientific Operations, Chief Operating Officer
Company Profile Activity
Activity Insights
Chase Theraputics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chase Theraputics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chase Theraputics.
Chase Theraputics Tech Stack
A closer look at the technologies used by Chase Theraputics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chase Theraputics
Sign Up For FreeTo access detailed company insights
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease. Chase Therapeutics mission is to improve the quality of life for patients with brain disease and their caregivers. Parkinsons disease and related neurodegenerative disorders currently lack a disease... Read More
